Nerve damage may raise stomach risks from popular diabetes drug
NCT ID NCT07156591
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 29 times
Summary
This study will observe 460 adults with diabetes who take semaglutide (a drug for diabetes) to see if those with nerve damage (neuropathy) are more likely to develop stomach retention, where food stays in the stomach too long. Participants will be split into two groups: those with neuropathy and those without. The goal is to understand if neuropathy increases the risk of this side effect, helping doctors make safer treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC RETENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huadong hospital, Fudan university
Shanghai, Shanghai Municipality, 200040, China
Conditions
Explore the condition pages connected to this study.